| Description | Giloralimab (ABBV-927), an agonistic monoclonal antibody targeting CD40, exhibits potent activity and is being investigated for potential application in cancer research [1] [2]. |
| Synonyms | ABBV-927 |
| molecular weight | N/A |
| CAS | 2226292-20-0 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |